Next Article in Journal
Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy
Next Article in Special Issue
Linking Cancer Metabolic Dysfunction and Genetic Instability through the Lens of Iron Metabolism
Previous Article in Journal
Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation
Previous Article in Special Issue
Starve Cancer Cells of Glutamine: Break the Spell or Make a Hungry Monster?
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessReview

Metabolic Regulation of Redox Balance in Cancer

Perlmutter Cancer Center, New York University, New York, NY 10016, USA
Department of Surgery, New York University, New York, NY 10016, USA
Department of Pathology, New York University, New York, NY 10016, USA
Departments of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA
Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA
Author to whom correspondence should be addressed.
Cancers 2019, 11(7), 955;
Received: 30 May 2019 / Revised: 1 July 2019 / Accepted: 2 July 2019 / Published: 8 July 2019
(This article belongs to the Special Issue Metabolic Reprogramming and Vulnerabilities in Cancer)
PDF [2084 KB, uploaded 8 July 2019]


Reactive oxygen species (ROS) are chemically active free radicals produced by partial reduction of oxygen that can activate discrete signaling pathways or disrupt redox homeostasis depending on their concentration. ROS interacts with biomolecules, including DNA, and can cause mutations that can transform normal cells into cancer cells. Furthermore, certain cancer-causing mutations trigger alterations in cellular metabolism that can increase ROS production, resulting in genomic instability, additional DNA mutations, and tumor evolution. To prevent excess ROS-mediated toxicity, cancer-causing mutations concurrently activate pathways that manage this oxidative burden. Hence, an understanding of the metabolic pathways that regulate ROS levels is imperative for devising therapies that target tumor cells. In this review, we summarize the dual role of metabolism as a generator and inhibitor of ROS in cancer and discuss current strategies to target the ROS axis. View Full-Text
Keywords: oxidative stress; antioxidants; ROS; NADPH oxidative stress; antioxidants; ROS; NADPH

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Purohit, V.; Simeone, D.M.; Lyssiotis, C.A. Metabolic Regulation of Redox Balance in Cancer. Cancers 2019, 11, 955.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top